As of Feb 03, 2025, Apple Relative Value is $246.2. This suggests it may be overvalued by 14.8% compared to its current price of around $288.9.
As of Feb 03, 2025, Amgen Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $539.6. This suggests it may be overvalued by 86.8% to its current price of around $288.9, using a discount rate of 5.9% and terminal growth rate of 3.0%.
As of Feb 03, 2025, Apple Intrinsic Value is $392.5. This suggests it may be undervalued by 35.9% compared to its current price of around $288.9.